Share Search
Visit the Share Search
Cizzle Biotech Accounts Summary
| Date of Accounts | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | IFRS |
| Millions | Millions | Millions | Millions | Millions | |
| Income Statement | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Revenue | n/a | n/a | n/a | n/a | n/a |
| Operating Profit / Loss | -0.75 | -2.19 | -1.76 | -0.96 | -3.96 |
| Net Interest | n/a | n/a | n/a | n/a | n/a |
| Pre Tax Profit | -0.75 | -2.19 | -1.76 | -0.96 | -3.96 |
| Post Tax Profit | -0.69 | -2.17 | -1.72 | -0.91 | -3.92 |
| Profit for the Period | -0.69 | -2.17 | -1.72 | -0.91 | -3.92 |
| Equity Holders of Parent Company | -0.69 | -2.17 | -1.72 | -0.91 | -3.92 |
| Minority Interests | n/a | n/a | n/a | n/a | n/a |
| Continuing EPS | |||||
| Earnings per Share (Basic) | -0.17p | -0.60p | -0.50p | -0.30p | -2.40p |
| Earnings per Share (Diluted) | -0.17p | -0.60p | -0.50p | -0.30p | -2.40p |
| Earnings per Share (Adjusted) | -0.17p | -0.60p | -0.50p | -0.30p | -2.40p |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | -0.17p | -0.60p | -0.50p | -0.30p | -2.40p |
| Earnings per Share (Diluted) | -0.17p | -0.60p | -0.50p | -0.30p | -2.40p |
| Earnings per Share (Adjusted) | -0.17p | -0.60p | -0.50p | -0.30p | -2.40p |
| Dividend per Share | n/ap | n/ap | n/ap | n/ap | n/ap |
| Millions | Millions | Millions | Millions | Millions | |
| Balance Sheet | 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 |
| Non-Current Assets | |||||
| Intangible Assets | n/a | n/a | n/a | 2.08 | 0.20 |
| Property, Plant and Equipment | n/a | n/a | n/a | n/a | n/a |
| Investments | n/a | n/a | n/a | n/a | n/a |
| Investment Properties | n/a | n/a | n/a | n/a | n/a |
| Other Financial Assets | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Assets | n/a | n/a | n/a | n/a | n/a |
| Total Non-Current Assets | n/a | n/a | n/a | 2.08 | 0.20 |
| Current Assets | |||||
| Inventories | n/a | n/a | n/a | n/a | n/a |
| Trade and Other Receivables | 0.13 | 0.10 | 0.14 | 0.23 | 0.08 |
| Cash at Bank and in Hand | 0.12 | 0.36 | 0.14 | 0.48 | 0.88 |
| Current Asset Investments | n/a | 0.02 | 1.41 | n/a | n/a |
| Other Current Assets | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | 0.24 | 0.49 | 1.69 | 0.70 | 0.96 |
| Other Assets | n/a | n/a | n/a | n/a | n/a |
| Total Assets | 0.24 | 0.49 | 1.69 | 2.79 | 1.16 |
| Current Liabilities | |||||
| Borrowings | n/a | n/a | n/a | n/a | n/a |
| Other Current Liabilities | 0.58 | 0.41 | n/a | 0.14 | 0.22 |
| Total Current Liabilities | 0.58 | 0.41 | n/a | 0.15 | 0.22 |
| Net Current Assets | n/a | n/a | n/a | n/a | n/a |
| Non-Current Liabilities | |||||
| Borrowings | n/a | n/a | n/a | n/a | n/a |
| Provisions | n/a | n/a | n/a | n/a | n/a |
| Other Non-Current Liabilities | n/a | n/a | 0.19 | n/a | n/a |
| Total Non-Current Liabilities | n/a | n/a | 0.19 | n/a | n/a |
| Net Assets | -0.34 | 0.08 | 1.51 | 2.64 | 0.94 |
| Capital and Reserves | |||||
| Share Capital | 3.51 | 3.51 | 3.50 | 3.50 | 3.49 |
| Share Premium Account | 35.91 | 35.91 | 35.34 | 34.92 | 32.57 |
| Other Reserves | -29.17 | -29.30 | -29.46 | -29.63 | -29.61 |
| Retained Earnings | -10.59 | -10.04 | -7.87 | -6.15 | -5.52 |
| Shareholders Funds | -0.34 | 0.08 | 1.51 | 2.64 | 0.94 |
| Minority Interests / Other Equity | n/a | n/a | n/a | n/a | n/a |
| Total Equity | -0.34 | 0.08 | 1.51 | 2.64 | 0.94 |
| 31-12-2025 | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 | |
| Operating Margin | n/a% | n/a% | n/a% | n/a% | n/a% |
| Return on Capital Employed | 220.88% | -2,667.07% | -116.99% | -171.96% | -537.04% |
| Dividend Cover | n/a | n/a | n/a | n/a | n/a |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | n/a | n/a | n/a | n/a | n/a |
| PEG | n/a | n/a | n/a | n/a | n/a |
| Dividend per Share Growth | n/a% | n/a% | n/a% | n/a% | n/a% |
| Net Asset Value per Share | -0.09p | 0.02p | 0.38p | 0.14p | 0.19p |